FDA to Participate in Covid-19 Diagnostics Evidence Accelerator

The FDA will participate in the Covid-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research.

• The accelerator will allow experts in health data to analyze diagnostic and clinical data in real time
• The accelerator will observe Covid-19 diagnostic tests and antibody tests and how they are best used to tailor testing strategies to specific populations
• “This collaboration with the FDA, scientists and data experts is meeting the urgency of the moment to speed the pace of diagnostic testing,”Ellen Sigal, Chair of both the ...